Skip to main content
. 2022 Dec 19;115(3):279–287. doi: 10.1093/jnci/djac220

Table 3.

Hazard ratios (95% confidence intervals) of death from cardiovascular disease comparing Hispanic, Non-Hispanic Asian, and Non-Hispanic Black to Non-Hispanic White survivors overall and by type of SPCs

SPC, race and ethnicity No. of deaths Model 1a Model 2a Model 3a
HR (95% CI) HR (95% CI) HR (95% CI)
All SPCs
 Hispanic 97 1.12 (0.91 to 1.38) 1.03 (0.82 to 1.29) 1.01 (0.78 to 1.29)
 Non-Hispanic Asian 61 0.83 (0.64 to 1.07) 0.89 (0.67 to 1.17) 0.83 (0.61 to 1.13)
 Non-Hispanic Black 196 1.67 (1.44 to 1.94) 1.47 (1.25 to 1.74) 1.44 (1.20 to 1.74)
 Non-Hispanic White 1422 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
Second breast cancerb
 Hispanic 36 1.04 (0.74 to 1.47) 0.86 (0.57 to 1.31) 0.91 (0.58 to 1.42)
 Non-Hispanic Asian 19 0.64 (0.41 to 1.02) 0.75 (0.45 to 1.23) 0.62 (0.35 to 1.12)
 Non-Hispanic Black 91 1.94 (1.55 to 2.43) 1.62 (1.25 to 2.09) 1.74 (1.30 to 2.32)
 Non-Hispanic White 479 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
Second lung cancer
 Hispanic 7 0.97 (0.45 to 2.06) 0.99 (0.45 to 2.15) 0.81 (0.32 to 2.02)
 Non-Hispanic Asian 10 1.62 (0.85 to 3.08) 1.80 (0.92 to 3.53) 1.86 (0.87 to 3.96)
 Non-Hispanic Black 24 1.80 (1.17 to 2.78) 1.31 (0.81 to 2.13) 1.08 (0.61 to 1.92)
 Non-Hispanic White 148 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
Second colorectal cancer
 Hispanic 18 1.76 (1.08 to 2.86) 1.60 (0.96 to 2.67) 1.54 (0.86 to 2.76)
 Non-Hispanic Asian 2 0.21 (0.05 to 0.86) 0.20 (0.05 to 0.83) 0.21 (0.05 to 0.86)
 Non-Hispanic Black 27 1.52 (1.01 to 2.28) 1.64 (1.07 to 2.50) 1.64 (1.02 to 2.64)
 Non-Hispanic White 203 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
Second uterine cancer
 Hispanic 4 1.02 (0.37 to 2.78) 1.16 (0.41 to 3.25) 0.89 (0.27 to 2.92)
 Non-Hispanic Asian 6 1.21 (0.53 to 2.78) 1.33 (0.57 to 3.13) 0.79 (0.24 to 2.59)
 Non-Hispanic Black 3 0.43 (0.14 to 1.37) 0.49 (0.15 to 1.60) 0.56 (0.17 to 1.83)
 Non-Hispanic White 98 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
a

Model 1 adjusted for age at diagnosis of SPC, year of diagnosis of SPC, and type of SPC (4 cancer groups based on 5-year relative survival rate. This is only for all SPC model); Model 2: Model 1 + tumor stage of SPC, treatment of SPC (surgery, chemotherapy, and radiation therapy), marital status, median household income, percent less than ninth grade, and region of registry at SPC diagnosis; Model 3: Model 2 + age at diagnosis of first breast cancer, tumor stage of first breast cancer, estrogen receptor status of first breast cancer, treatment of first breast cancer (surgery, chemotherapy, and radiation therapy). CI = confidence interval; HR = hazard ratio; SPC = second primary cancer.

b

Model 2 and 3 further adjusted for estrogen receptor status of the second breast cancer.